Sort
85,873 grants matching “alzheimers”
North American Prodromal Synucleinopathy Consortium for RBD, Stage 2 (NAPS2)
$7,732,841Yo-El S Ju · Washington University · U19 · FY2021 · AG
Clinical Core
$7,709,141Bradley F Boeve · Mayo Clinic Rochester · U19 · FY2023 · AG
Alzheimer's Gut Microbiome Project
$7,690,237Rima F Kaddurah-Daouk · Duke University · U19 · FY2023 · AG
Preclinical AD Consortium
$7,661,777Marilyn S Albert · Johns Hopkins University · RF1 · FY2018 · AG
Early Onset Alzheimer's Disease Consortium
$7,654,317Liana G Apostolova · Indiana University Indianapolis · R56 · FY2017 · AG
Clinical Core
$7,627,451Bradley F Boeve · Mayo Clinic Rochester · U19 · FY2021 · AG
Generation, Characterization, and Validation of Marmoset Models of Alzheimer's Disease
$7,623,844Afonso C Silva · University Of Pittsburgh At Pittsburgh · U19 · FY2025 · AG
Clinical Core
$7,614,416Bradley F Boeve · Mayo Clinic Rochester · U19 · FY2024 · AG
Engagement Core
$7,611,842Monica G Rivera-Mindt · Northern California Institute/Res/Edu · U19 · FY2023 · AG
University of Miami Federated Biorepository Facility to Advance Biomedical Research
$7,600,000Jacob L McCauley · University Of Miami School Of Medicine · C06 · FY2020 · OD
Genomic Characterization of Alzheimer's Disease Risk in the Puerto Rican Population
$7,588,174Margaret A Pericak-Vance · University Of Miami School Of Medicine · RF1 · FY2016 · AG
Add Health Parent Study: A Biosocial Resource for the Study of Multigenerational Racial/Ethnic Disparities in Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD)
$7,584,228Kathleen Mullan Harris · Univ Of North Carolina Chapel Hill · R01 · FY2025 · AG
Alzheimer's Disease Neuroimaging Initiative
$7,560,001Michael W Weiner · Northern California Institute/Res/Edu · U01 · FY2013 · AG
Allopregnanolone as Regenerative Therapeutic for Alzheimer's: Phase 2 Clinical Trial
$7,552,351Roberta Diaz Brinton · University Of Arizona · R01 · FY2022 · AG
University of Kentucky Center for Clinical and Translational Science Enterprise Data Center Expansion
$7,548,058Philip A Kern · University Of Kentucky · C06 · FY2024 · OD
Protective Genetic Variants for Alzheimer Disease in the Amish
$7,537,708Jonathan L. Haines · Case Western Reserve University · RF1 · FY2017 · AG
Educational and Early Life Predictors of Mild Cognitive Impairment: New Evidence about Mediators and Moderators from High School & Beyond
$7,534,484John Robert Warren · University Of Minnesota · R01 · FY2021 · AG
Clinical Core
$7,531,603Bradley F Boeve · Mayo Clinic Rochester · U19 · FY2020 · AG
Plasma Proteomic Signatures for Alzheimer's Disease and Related Dementias
$7,523,227Aladdin Shadyab · University Of California, San Diego · RF1 · FY2022 · AG
Open Drug Discovery Center for Alzheimer's Disease
$7,498,878Allan I Levey · Emory University · U54 · FY2019 · AG
Topographic, cell type and molecular pathway characterization ofAlzheimer's disease using single cell transcriptomics and epigenomics
$7,490,446Ed Lein · Allen Institute · U19 · FY2022 · AG
IUSM Alzheimer's Disease Drug Discovery Center
$7,457,353Alan D. Palkowitz · Indiana University Indianapolis · U54 · FY2020 · AG
IUSM Alzheimer's Disease Drug Discovery Center
$7,452,927Alan D. Palkowitz · Indiana University Indianapolis · U54 · FY2021 · AG
iPSC Neurodegenerative Diseases Initiative
$7,452,174Andrew Singleton · National Institute On Aging · ZIA · FY2020 · AG
Prenatal Diagnosis Of Congenital Anomalies
$7,431,578Roberto Romero · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2013 · HD